Gabriel Márquez Perera

Title: Gabriel Márquez Perera: Innovator in Immunology

Introduction

Gabriel Márquez Perera is a notable inventor based in Ciudad de la Habana, Cuba. He has made significant contributions to the field of immunology, particularly in the development of therapeutic polypeptides. His work focuses on enhancing the immune response, which is crucial in treating various diseases, including cancer.

Latest Patents

Gabriel Márquez Perera holds 1 patent for his invention titled "Immunomodulatory interleukin-2 polypeptides and methods of treating melanoma." This invention relates to polypeptides that exhibit high sequence homology with human interleukin 2 (IL-2), incorporating specific mutations to enhance their immunomodulatory effects. The polypeptides are designed to selectively target regulatory T cells, thereby improving the immune system's response to diseases such as melanoma and chronic infections. The invention also includes pharmaceutical compositions that utilize these polypeptides as active ingredients.

Career Highlights

Gabriel Márquez Perera is affiliated with the Centro de Inmunología Molecular, where he conducts research and development in immunotherapy. His innovative approach to immunomodulation has positioned him as a key figure in the advancement of treatments for immune-related diseases.

Collaborations

He has collaborated with notable colleagues, including Kalet León Monzón and Tania Carmenate Portilla, contributing to the collective efforts in the field of immunology.

Conclusion

Gabriel Márquez Perera's work exemplifies the intersection of innovation and medical science, particularly in the development of therapies that harness the power of the immune system. His contributions are vital in the ongoing fight against diseases like cancer, showcasing the importance of research and invention in improving health outcomes.